Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine nasal drops for postoperative analgesia after laparoscopic cholecystectomy
ChiCTR2100052531Phase 4Recruiting
- Sponsor
- Qionglai Medical Center Hospital
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in Cholecystolithiasis (2 arms), sponsored by Qionglai Medical Center Hospital. Primary endpoint: Visual analogue scale pain score. Started Nov 2021; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Cholecystolithiasis
Beyond the preview
Go deeper on ChiCTR2100052531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052531.